UNIGE document Scientific Article
previous document  unige:92561  next document
add to browser collection

Psychopharmacological treatment in pathological gambling: a critical review

Published in Current pharmaceutical design. 2011, vol. 17, no. 14, p. 1389-95
Abstract Given the rates of pathological gambling and its impact on affected individuals and their relatives, effective treatments are needed. There are, however, no approved pharmacological treatments for pathological gambling. This paper describes the development of pharmacological treatments for pathological gambling and is based on a review of the literature published in the past 10 years. Important studies were carried-out on antidepressants, mood stabilizers, and antipsychotic agents. In the absence of comorbid psychiatric disorder, these studies did not conclude to the efficacy of these psychotropic drugs. A possible efficacy of opiate antagonist treatment for pathological gambling has been replicated in a number of placebo-controlled studies. Preliminary results on N-acetyl cysteine, Memantine and Topiramate produced significant improvement for pathological gamblers and may open new avenues for treatment.
Keywords AnimalsAntidepressive Agents/therapeutic useAntimanic Agents/therapeutic useAntipsychotic Agents/therapeutic useDrug DesignGambling/drug therapy/psychologyHumansPsychotropic Drugs/therapeutic use
PMID: 21524264
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
Research group Abus de substances (834)
(ISO format)
ACHAB, Sophia, KHAZAAL, Yasser. Psychopharmacological treatment in pathological gambling: a critical review. In: Current pharmaceutical design, 2011, vol. 17, n° 14, p. 1389-95. https://archive-ouverte.unige.ch/unige:92561

269 hits

0 download


Deposited on : 2017-03-14

Export document
Format :
Citation style :